Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]

chronic-disease

Endovascular thrombectomy 6 to 24-hours after anterior circulation stroke significantly reduces disability rates

1. Patients in the thrombectomy group reported a greater independence in daily living compared to those receiving best medical therapy alone. 2. 90-day mortality did not differ between the thrombectomy and best medical therapy groups. Evidence Rating Level: 1 (Excellent) Study Rundown: There exists extensive evidence around the use of mechanical thrombectomy for patients with […]

Read More

mRNA-1273 vaccine reduces risk of Covid-19-related outcomes compared to BNT162b2 in U.S. veterans

1. The mRNA-1273 vaccine was shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans compared to BNT162b2 vaccine. 2. Both mRNA-1273 and BNT162b2 vaccines were shown to reduce the absolute risk of Covid-19-related outcomes in U.S. veterans. Evidence Rating Level: 2 (Good)      Study Rundown: To help combat the SARS-CoV-2 (Covid-19) pandemic, messenger […]

Read More

Extreme prematurity associated with increased prevalence of visual and ocular deficits in young adults

1. Extreme prematurity was associated with an increased prevalence of visual and ocular deficits, suggesting children born extremely preterm may have residual ophthalmic sequelae persisting into adulthood. 2. These findings emphasized the need for screening and management of any deficits as they evolve long-term at a population-level. Evidence Rating Level: 2 (Good) Study Rundown: Although […]

Read More

Hybrid closed-loop therapy improves glycemic control for children with Type 1 Diabetes

1. In very young children with type 1 diabetes, a hybrid closed-loop therapy provided significantly improved glycemic children. 2. The hybrid closed-loop therapy did not significantly increase the time spent in hypoglycemia in very young children with type 1 diabetes. Evidence Rating Level: 1 (Excellent) Study Rundown: In very young children, managing Type 1 Diabetes […]

Read More

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases

1. Treatment with alectinib reduced CNS lesion sizes and significantly improved symptoms, ECOG performance scores and requirements for mannitol and corticosteroids in patients with metastases from non-small cell lung cancer. Evidence Level Rating: 2 (Good) Central nervous system metastases are highly prevalent in patients with ALK gene mutations driving advanced non-small cell lung cancer despite […]

Read More

For latest news and updates
Email-id is invalid